InsiderTrades

Form 4 for MDLN Medline Inc.

Accepted 2025-12-22 00:00:00 ET · period of report 2025-12-16 · accession 0001193125-25-328814 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DI 2025-12-22 2025-12-16 MDLN Mills Andrew J. Dir A - Grant — +30.7K 30.7K New —
DI 2025-12-22 2025-12-18 MDLN Mills Andrew J. Dir P - Purchase $29.00 +2.59M 2.59M New +$75.00M
DI 2025-12-22 2025-12-16 MDLN Mills Andrew J. Dir A - Grant — +30.7K 30.7K New —

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class B Common Stock 2025-12-16 A A 30,655 — 30,655 I See Footnote — — (F1) These securities were acquired in connection with the reclassification of the interests of Medline Holdings, LP prior to the Issuer's initial public offering (as more fully described in the Registration Statement on Form S-1). These securities were previously reported on the Reporting Person's Form 3 filed on December 17, 2025. (F2) These securities are held by a trust for the benefit of the Reporting Person and members of his immediate family, and of which the Reporting Person has the power to replace the trustee. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
2 Common Class A Common Stock 2025-12-18 P A 2,586,206 $29.00 2,586,206 I See Footnote — — (F4) These securities are held for the benefit of the Reporting Person and members of his immediate family by a limited liability company. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
3 Derivative Common Units of Medline Holdings, LP 2025-12-16 A A 30,655 — 30,655 I See Footnote — · — to — 30,655 Class A Common Stock (F1) These securities were acquired in connection with the reclassification of the interests of Medline Holdings, LP prior to the Issuer's initial public offering (as more fully described in the Registration Statement on Form S-1). These securities were previously reported on the Reporting Person's Form 3 filed on December 17, 2025. (F2) These securities are held by a trust for the benefit of the Reporting Person and members of his immediate family, and of which the Reporting Person has the power to replace the trustee. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. (F5) Pursuant to the terms of an exchange agreement, dated as of December 16, 2025, holders have the right to exchange their common units of Medline Holdings, LP for shares of the Issuer's Class A common stock on a one-for-one basis, subject to customary conversion rate adjustments for stock splits, stock dividends and reclassifications. These exchange rights do not expire.